IOBT
IO Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · DK
$0.01
−27.59%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-98.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 6, 2025 | Smith David V · director | A-Award | 35,144 | $1.50 |
| Jun 6, 2025 | Hunter Heidi · director | A-Award | 35,144 | $1.50 |
| Jun 6, 2025 | Hirth Peter · director | A-Award | 35,144 | $1.50 |
| Jun 6, 2025 | Glaub Kathleen Sereda · director | A-Award | 35,144 | $1.50 |
| Jun 6, 2025 | Elling Christian E · director | A-Award | 35,144 | $1.50 |
| Jun 6, 2025 | Collins Helen Louise · director | A-Award | 35,144 | $1.50 |
| Jun 2, 2025 | Hunter Heidi · director | Purchase | 15,000 | $1.39 |
| Apr 4, 2025 | Zocca Mai-Britt · director, officer: Chief Executive Officer | A-Award | 580,000 | $1.07 |
| Apr 4, 2025 | Sullivan Amy · officer: Chief Financial Officer | A-Award | 215,000 | $1.07 |
| Apr 4, 2025 | Smith Devin Whittemore · officer: General Counsel | A-Award | 140,000 | $1.07 |
| Apr 4, 2025 | Burkavage Brian · officer: Chief Accounting Officer | A-Award | 65,000 | $1.07 |
| Apr 4, 2025 | Ahmad Qasim Iftikhar · officer: Chief Medical Officer | A-Award | 215,000 | $1.07 |
| Dec 26, 2024 | Ahmad Qasim Iftikhar · officer: Chief Medical Officer | Purchase | 31,350 | $0.85 |
| Dec 23, 2024 | Zocca Mai-Britt · director, officer: Chief Executive Officer | Purchase | 12,500 | $0.81 |
| Dec 23, 2024 | Sullivan Amy · officer: Chief Financial Officer | Purchase | 10,250 | $0.83 |
| Dec 23, 2024 | Smith Devin Whittemore · officer: General Counsel | Purchase | 12,000 | $0.81 |
| Jul 26, 2024 | Novo Holdings A/S · 10 percent owner | Sale | 51,522 | $1.33 |
| Jul 26, 2024 | Novo Holdings A/S · 10 percent owner | Sale | 23,478 | $1.31 |
| Jun 7, 2024 | Smith David V · director | A-Award | 45,642 | $1.25 |
| Jun 7, 2024 | Hunter Heidi · director | A-Award | 45,642 | $1.25 |
| Jun 7, 2024 | Hirth Peter · director | A-Award | 45,642 | $1.25 |
| Jun 7, 2024 | Glaub Kathleen Sereda · director | A-Award | 45,642 | $1.25 |
| Jun 7, 2024 | Elling Christian E · director | A-Award | 45,642 | $1.25 |
| Jun 7, 2024 | Collins Helen Louise · director | A-Award | 45,642 | $1.25 |
| May 14, 2024 | Novo Holdings A/S · 10 percent owner | Sale | 658,809 | $1.22 |
| Mar 18, 2024 | Zocca Mai-Britt · director, officer: Chief Executive Officer | A-Award | 750,000 | $1.65 |
| Mar 18, 2024 | Sullivan Amy · officer: Chief Financial Officer | A-Award | 280,000 | $1.65 |
| Mar 18, 2024 | Smith Devin Whittemore · officer: General Counsel | A-Award | 185,000 | $1.65 |
| Mar 18, 2024 | Burkavage Brian · officer: Chief Accounting Officer | A-Award | 50,000 | $1.65 |
| Mar 18, 2024 | Ahmad Qasim Iftikhar · officer: Chief Medical Officer | A-Award | 280,000 | $1.65 |
Institutional positioning
13F filings over the trailing two quarters
New 2Increased 2Reduced 5Sold out 13
| Filer | Action | Shares | Filed |
|---|---|---|---|
| IKARIAN CAPITAL, LLC | Unchanged | 1,386,565 | May 15, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | Unchanged | 451,852 | May 15, 2026 |
| GSA CAPITAL PARTNERS LLP | New Position | 348,352 | May 8, 2026 |
| MARSHALL WACE, LLP | Reduced | 301,291 | May 15, 2026 |
| XTX TOPCO LTD | Increased | 265,792 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 206,215 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 194,158 | May 15, 2026 |
| CITIGROUP INC | Reduced | 72,495 | May 11, 2026 |
| JANE STREET GROUP, LLC | New Position | 57,974 | May 12, 2026 |
| BEACON POINTE ADVISORS, LLC | Reduced | 42,600 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Unchanged | 33,307 | May 15, 2026 |
| UBS GROUP AG | Reduced | 30,980 | May 5, 2026 |
| XTX Topco Ltd | Sold Out | 0 | May 15, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
| JANE STREET GROUP, LLC | Sold Out | 0 | May 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 6, 2025